Differentiating ES cells using a tenascin
US9334478B2 · kind B2 · utility
1Cited by
24References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2009 |
| Grant date | May 10, 2016 |
| Priority date | — |
| Expiry date | Sep 10, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to assays for screening growth factors, adhesion molecules, immunostimulatory molecules, extracellular matrix components and other materials, alone or in combination, simultaneously or temporally, for the ability to induce directed differentiation of pluripotent and multipotent stem cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.